Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2014
Tolvaptan delays the onset of end-stage renal disease in a polycystic kidney disease model by suppressing increases in kidney volume and renal injuryMiki Aihara, Hiroyuki Fujiki, Hiroshi Mizuguchi, et al.
Diseases of the Colon and Rectum|February 11, 2003
Survival after curative resection for mucinous adenocarcinoma of the colorectumYukihide Kanemitsu, Tomoyuki Kato, Takashi Hirai, et al.
World Journal of Clinical Oncology|October 14, 2011
Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapyKenji Ina, Ryuichi Furuta, Takae Kataoka, et al.
Surgery Today|March 24, 2006
Laparoscopic wedge resection for gastrointestinal stromal tumors of the stomach: initial experienceYoshinari Mochizuki, Yasuhiro Kodera, Michitaka Fujiwara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Intestinal trefoil factor: a marker of poor prognosis in gastric carcinomaTakasuke Yamachika, J Lawrence Werther, Carol Bodian, et al.
Journal of Pharmacological Sciences|April 27, 2004
Antidiuretic effects of a novel nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to dogsShigeki Nakamura, Takahiro Hirano, Toshiyuki Onogawa, et al.
Japanese Journal of Clinical Oncology|September 30, 2008
Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1Kohei Shitara, Kei Muro, Takashi Ura, et al.
Hepato-Gastroenterology|July 9, 2004
Obesity and outcome of distal gastrectomy with D2 lymphadenectomy for carcinomaYasuhiro Kodera, Seiji Ito, Yoshitaka Yamamura, et al.
Anti-Cancer Drugs|January 24, 2006
Phase II study of a 4-week capecitabine regimen in advanced or recurrent gastric cancerJunichi Sakamoto, Keisho Chin, Ken Kondo, et al.
Pageof 8